← Eichor
Study identifier: NCT05968417 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Myeloma Novel Drug Discovery Ver 1.2

Condition: Multiple Myeloma  ·  Sponsor: Institute of Cancer Research, United Kingdom

PhaseN/A
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year. Researchers are committed to improving understanding of myeloma and developing more effective treatments with fewer side effects in order to improve patient outcomes. In order to do this, researchers are collecting samples of blood and bone marrow to test the activity of potential new treatments in the laboratory and to understand what may be the cause of some treatments not working.

This description comes directly from the study's public registry record.

Talk to the study team

Disco Team  ·  020 3186 5275  ·  Disco.iras263630@nhs.net

Always discuss trial participation with your own doctor first.

Locations (1)

The Royal Marsden NHS Foundation TrustSutton, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05968417